Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis

The aim was to evaluate the relationship between gut dysbiosis and hemodynamic changes (hyperdynamic circulation) in cirrhosis, and between hemodynamic changes and complications of this disease. This study included 47 patients with cirrhosis. Stool microbiome was assessed using 16S rRNA gene sequencing. Echocardiography with a simultaneous assessment of blood pressure and heart rate was performed to assess systemic hemodynamics. Patients with hyperdynamic circulation had more severe cirrhosis, lower albumin, sodium and prothrombin levels, higher C-reactive protein, aspartate aminotransferase and total bilirubin levels, and higher incidences of portopulmonary hypertension, ascites, overt hepatic encephalopathy, hypoalbuminemia, hypoprothrombinemia, systemic inflammation, and severe hyperbilirubinemia than patients with normodynamic circulation. Patients with hyperdynamic circulation compared with those with normodynamic circulation had increased abundance of Proteobacteria, Enterobacteriaceae, Bacilli, Streptococcaceae, Lactobacillaceae, Fusobacteria, Micrococcaceae, Intestinobacter, Clostridium sensu stricto, Proteus and Rumicoccus, and decreased abundance of Bacteroidetes, Bacteroidaceae, Holdemanella, and Butyrivibrio. The systemic vascular resistance and cardiac output values correlated with the abundance of Proteobacteria, Enterobacteriaceae, Bacilli, Streptococcaceae, Lactobacillaceae, Micrococcaceae, and Fusobacteria. Heart rate and cardiac output value were negatively correlated with the abundance of Bacteroidetes. The mean pulmonary artery pressure value was positively correlated with the abundance of Proteobacteria and Micrococcaceae, and negatively with the abundance of Holdemanella.

[1]  E. Shirokova,et al.  Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link? , 2021, World Journal of Clinical Cases.

[2]  E. Shirokova,et al.  Probiotics in hepatology: An update , 2021, World journal of hepatology.

[3]  M. Friedrich-Rust,et al.  Easl Clinical Practice Guidelines (Cpgs) On Non-Invasive Tests For Evaluation Of Liver Disease Severity And Prognosis- 2020 Update. , 2021, Journal of hepatology.

[4]  K. Ivashkin,et al.  Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis , 2021, World journal of hepatology.

[5]  A. Sonnenberg,et al.  Transjugular Liver Biopsy with Hemodynamic Evaluation: Correlation between Hepatic Venous Pressure Gradient and Histologic Diagnosis of Cirrhosis , 2021, Journal of clinical imaging science.

[6]  O. Koren,et al.  Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma , 2020, mSystems.

[7]  F. Wang,et al.  Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma , 2020, Cancer Medicine.

[8]  Robert D. Stedtfeld,et al.  Featured Gut Microbiomes Associated With the Progression of Chronic Hepatitis B Disease , 2020, Frontiers in Microbiology.

[9]  Q. Ou,et al.  Gut microbiota dysbiosis in patients with hepatitis B virus–induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma , 2020, Journal of viral hepatitis.

[10]  C. Pavlov,et al.  Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis? , 2019, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[11]  M. Trauner,et al.  Gut-liver axis signaling in portal hypertension , 2019, World journal of gastroenterology.

[12]  T. Ohkusa,et al.  Characterisation of blood microbiota in patients with liver cirrhosis , 2019, European journal of gastroenterology & hepatology.

[13]  I. Martínez,et al.  Faecal microbiota from patients with cirrhosis has a low capacity to ferment non‐digestible carbohydrates into short‐chain fatty acids , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[14]  Guangxiu Liu,et al.  Relationship between intestinal microbial dysbiosis and primary liver cancer. , 2019, Hepatobiliary & pancreatic diseases international : HBPD INT.

[15]  K. Reddy,et al.  Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  C. Pavlov,et al.  Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis , 2018, Hepatology International.

[17]  K. Ivashkin,et al.  NT-proBNP as a biomarker for hyperdynamic circulation in decompensated cirrhosis , 2018, Gastroenterology and hepatology from bed to bench.

[18]  H. Yoshiji,et al.  Gut Dysbiosis Associated With Hepatitis C Virus Infection , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  A. Gasbarrini,et al.  Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications , 2018, Expert review of gastroenterology & hepatology.

[20]  Huinan Chen,et al.  Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis , 2018, Front. Physiol..

[21]  F. Bendtsen,et al.  The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[22]  Paolo Angeli,et al.  Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis , 2017, Journal of Vascular Research.

[23]  P. Hylemon,et al.  Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis , 2016, Scientific Reports.

[24]  M. Krowka,et al.  Current Approach to the Diagnosis and Management of Portopulmonary Hypertension , 2016, Current Gastroenterology Reports.

[25]  Alan D. Kaye,et al.  Minimally invasive or noninvasive cardiac output measurement: an update , 2016, Journal of Anesthesia.

[26]  Gregory A. Buck,et al.  MeFiT: merging and filtering tool for illumina paired-end reads for 16S rRNA amplicon sequencing , 2015, BMC Bioinformatics.

[27]  R. Genco,et al.  An accurate and efficient experimental approach for characterization of the complex oral microbiota , 2015, Microbiome.

[28]  P. Hylemon,et al.  Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy , 2015, Hepatology.

[29]  Ó. O’Sullivan,et al.  The Effects of Freezing on Faecal Microbiota as Determined Using MiSeq Sequencing and Culture-Based Investigations , 2015, PloS one.

[30]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[31]  Y. Sanz,et al.  Gut microbiota-related complications in cirrhosis. , 2014, World Journal of Gastroenterology.

[32]  Andmorgan R. Fisher,et al.  Altered profile of human gut microbiome is associated with cirrhosis and its complications. , 2014, Journal of hepatology.

[33]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[34]  A. Gatta,et al.  Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis. , 2014, World journal of gastroenterology.

[35]  H. Nittono,et al.  Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. , 2013, Journal of hepatology.

[36]  Baoli Zhu,et al.  Characterization of fecal microbial communities in patients with liver cirrhosis , 2011, Hepatology.

[37]  J. Tiedje,et al.  Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.

[38]  Yves Lecarpentier,et al.  New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. , 2004, Chest.

[39]  I. Poxton,et al.  Biological activity of Bacteroides lipopolysaccharide--reappraisal. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  R. Berg,et al.  Translocation of Certain Indigenous Bacteria from the Gastrointestinal Tract to the Mesenteric Lymph Nodes and Other Organs in a Gnotobiotic Mouse Model , 1979, Infection and immunity.

[41]  J. Gottdiener,et al.  Recommendationsontheuseofechocardiography in adult hypertension : a report from the European Association of Cardiovascular Imaging ( EACVI ) and the American Society of Echocardiography ( ASE ) † , 2015 .

[42]  J. Voigt,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[43]  M. Rubenfire,et al.  Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. , 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[44]  Graham R D Jones,et al.  Reference intervals. , 2008, The Clinical biochemist. Reviews.